Company intelligence / Profile preview

BioPioneer

San Diego, California, United Statesbiopioneerinc.com ↗

Ownership: Private
Development stage: Other

Overview

BioPioneer in India has developed a novel protease inhibitor with high thermal and pH stability, water solubility, negligible toxicity, and strong efficacy against protein degradation during sample preparation. It is used by academic labs and R&D groups for improved protein isolation outcomes. No clinical results as it is not a therapeutic product. BioPioneer Inc in the US supplies laboratory plastics, equipment, antibodies, assay kits, and related life science consumables to researchers globally.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Non-Drug Biotech

Partnerships

KIIT-TBI incubator (Biopioneer India)BIRAC/DBT Govt of India (Biopioneer India)

Beyond the preview

Go deeper on BioPioneer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioPioneer.

Explore the full profile